Prime Medicine, Inc. Common Stock
Symbol: PRME (NASDAQ)
3.64
▲ (0.11%) 0.004
Company Description:
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Key Stats
- Today's Open: $3.64
- Today's High: $3.719
- Today's Low: $3.535
- Today's Volume: 4.08M
- Yesterday Close: $3.64
- Yesterday High: $3.778
- Yesterday Low: $3.5802
- Yesterday Volume: 2.38M
- Last Min Volume: 200
- Last Min High: $3.644
- Last Min Low: $3.642
- Last Min VWAP: $3.644
Company Profile
- Name: Prime Medicine, Inc. Common Stock
- Website: https://www.primemedicine.com
- Listed Date: 2022-10-20
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001894562
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $636.44M
- Round Lot: 100
- Outstanding Shares: 178.27M
- Asset Type: CS
RECENT FILINGS FOR PRME
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-11 | SCHEDULE 13D/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-07-31 | 8-K | View |
| 2025-07-31 | 424B5 | View |
Latest News on PRME